CoChat

Nationwide real-world implementation of AI for cancer detection in population-based mammography screening

Open access
Eisemann, Nora, Bunk, Stefan, Mukama, Trasias, Baltus, Hannah, Elsner, Susanne A., Gomille, Timo, Hecht, Gerold, Heywang-Köbrunner, Sylvia, Rathmann, Regine, Siegmann-Luz, Katja, Töllner, Thilo, Vomweg, Toni Werner, Leibig, Christian, Katalinic, Alexander · 2025 · Nature Medicine
Cited by 217

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Artificial intelligence (AI) in mammography screening has shown promise in retrospective evaluations, but few prospective studies exist. PRAIM is an observational, multicenter, real-world, noninferiority, implementation study comparing the performance of AI-supported double reading to standard double reading (without AI) among women (50–69 years old) undergoing organized mammography screening at 12 sites in Germany. Radiologists in this study voluntarily chose whether to use the AI system. From July 2021 to February 2023, a total of 463,094 women were screened (260,739 with AI support) by 119 radiologists. Radiologists in the AI-supported screening group achieved a breast cancer detection rate of 6.7 per 1,000, which was 17.6% (95% confidence interval: +5.7%, +30.8%) higher than and statistically superior to the rate (5.7 per 1,000) achieved in the control group. The recall rate in the AI group was 37.4 per 1,000, which was lower than and noninferior to that (38.3 per 1,000) in the control group (percentage difference: −2.5% (−6.5%, +1.7%)). The positive predictive value (PPV) of recall was 17.9% in the AI group compared to 14.9% in the control group. The PPV of biopsy was 64.5% in the AI group versus 59.2% in the control group. Compared to standard double reading, AI-supported double reading was associated with a higher breast cancer detection rate without negatively affecting the recall rate, strongly indicating that AI can improve mammography screening metrics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-024-03408-6

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 217

Metadata

Authors
Eisemann, N., Bunk, S., Mukama, T., Baltus, H., Elsner, S. A., Gomille, T., Hecht, G., Heywang-Köbrunner, S., Rathmann, R., Siegmann-Luz, K., Töllner, T., Vomweg, T. W., Leibig, C., & Katalinic, A.
Venue
Nature Medicine
Published
2025-01-07
Volume
31
Issue
3
Pages
917-924
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4406150594
Cited by
217
References
7
FWCI
90.30
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nationwide real-world implementation of AI for cancer detection in population-based mammography screening. https://app.cochat.ai/papers/10.1038/s41591-024-03408-6
The paper
Eisemann, N., Bunk, S., Mukama, T., Baltus, H., Elsner, S. A., Gomille, T., Hecht, G., Heywang-Köbrunner, S., Rathmann, R., Siegmann-Luz, K., Töllner, T., Vomweg, T. W., Leibig, C., & Katalinic, A. (2025). Nationwide real-world implementation of AI for cancer detection in population-based mammography screening. Nature Medicine. https://doi.org/10.1038/s41591-024-03408-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.